ABSTRACT
Objective: During neuraxial anaesthesia, correct patient positioning is key for increased block success and (patient) comfort. The aim of this prospective study was to compare the lateral fetal decubitus (LFD) position with the sitting fetal lotus (SFL) regarding interspinous distance, transverse diameters of paravertebral muscles measured with ultrasonography, and patient comfort. Methods: Fifty adult participants who could sit cross-legged and had no lumbar anomalies were included in our prospective study. In both SFL and LFD positions, measurements were performed with ultrasonography; in the axial plane, interspinous distance at the level of L4-L5, in the sagittal plan, with the probe slightly tilted, subcutaneous tissue-spinous process depth, and transverse diameters of paravertebral muscles were measured. Stretcher, waist position, and abdominal comfort were scored on a scale of 1 (very bad) to 7 (perfect) with a verbal numeric satisfaction scale. Results: Interspinous distance was significantly larger in the SFL position than in the LFD position (P < 0.05). There was no significant difference between the two positions (P > 0.05) regarding patient comfort. Paravertebral muscle diameters were significantly broader in the SFL position than in the LFD position. The diameter of the left paravertebral muscle in the SFL position (45.8±8.8 mm) was larger than that in the LFD position (43±7.8 mm; P < 0.001). The diameter of the right paravertebral muscle in the SFL position was (47±9 mm) larger than that in the LFD position (43.4±7.6 mm; P < 0.001). Conclusion: Although there was no difference regarding the comfort between the two positions, the interspinous distance was larger in the SFL position than in the LFD position.
ABSTRACT
BACKGROUND: In some stent implanted patients, cardiovascular events (CE) may occur. Acetylsalicylic acid (ASA) is routinely administered to these patients in order to prevent the occurrence of CE. CE may be related to gene variations which cause ASA resistance (AR). Therefore, it was aimed to investigate the relationship between COX-1, COX-2, CYP2C9 and CYP2C19 variations with CE due to AR. MATERIALS AND RESULTS: Seventy-four stent implanted patients, using 100 mg of ASA per day during five years were enrolled into the study. Following stent implantation, thirty-eight patients who had a CE within five years due to AR and 36 patients without CE were enrolled in patient and control group, respectively. AR was confirmed by platelet aggregation testing. After DNA isolation from blood; COX-1, COX-2, CYP2C19 and CYP2C9 variations were investigated with real-time polymerase chain reaction. At the end of this study, heterozygous genotype of COX-1 was found statistically high in patients whereas heterozygous genotype of CYP2C19*17 was found statistically high in controls. The presence of C and G allele in COX-1 and COX-2 were found statistically high in patients, respectively. The presence of T allele in CYP2C19*17 was found statistically high in controls. Heterozygous genotype of COX-1 variation was found statistically high in patients who have AR. Additionally heterozygous genotype of CYP2C19*17 was found statistically high in patients who have low thrombosis risk. CONCLUSIONS: COX-1 and COX-2 gene mutations may increase the risk of CE due to AR whereas CYP2C19*17 may have a protective effect in this process.
